About infectious disease diagnostic
Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.
Technavio's analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.
Covered in this report
The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
Molecular diagnostic test
POC infectious disease diagnostics test
POC infectious disease diagnostics test is classified into the following based on application:
Respiratory
HIV
HAIs
Sexual health
Tropical diseases
Liver
Technavio's report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market
Key regions
Americas
APAC
EMEA
Key vendors
Abbott Diagnostic
Alere
bioMérieux
Diasorin
Roche Diagnostic
Other prominent vendors
Beckman Coulter
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
J.Mitra
Meridian Bioscience
OraSure Technologies
ORGENTEC Diagnostika
Ortho Clinical Diagnostics
QIAGEN
Quidel
Siemens Healthcare Diagnostics
TECHLAB
Thermo Fisher Scientific
Trinity Biotech
Key market driver
Increase in prevalence of infectious diseases
For a full, detailed list, view our report
Key market challenge
Emerging infectious diseases
For a full, detailed list, view our report
Key market trend
Advances in technology
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by technology
Molecular diagnostic tests
POC infectious disease diagnostic tests
PART 07: Market segmentation by application
Global POC infectious disease diagnostic testing market by application
Respiratory
HIV
Healthcare-associated infections
Sexual health
Tropical diseases
Liver infections
PART 08: Market segmentation by product
Assay kits and consumables
Instruments
Services
PART 09: Geographical segmentation
Infectious disease diagnostic testing market in Americas
Infectious disease diagnostic testing market in EMEA
Infectious disease diagnostic testing market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
Abbott Diagnostics
Alere
bioMérieux
DiaSorin
Roche Diagnostics
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global infectious disease diagnostic testing market by technology
Exhibit 05: Global infectious disease molecular diagnostic testing market 2014-2019 ($ billions)
Exhibit 06: Global POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 07: Segmentation of global POC infectious disease diagnostic testing market by application 2014
Exhibit 08: Global respiratory POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 09: Demographic statistics for HIV 2014
Exhibit 10: Global HIV POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 11: Global HAIs POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 12: Global sexual health POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 13: Global tropical disease POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 14: Global liver POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 15: Global POC infectious disease diagnostic testing market by application 2014-2019
Exhibit 16: Segmentation of global infectious disease diagnostic testing by product
Exhibit 17: Segmentation of global infectious disease testing market by product 2014
Exhibit 18: Segmentation of global infectious disease diagnostic testing market by geography 2014
Exhibit 19: Segmentation of global infectious disease diagnostic testing market by geography 2019
Exhibit 20: Segmentation of global infectious disease diagnostic testing market by geography 2014-2019
Exhibit 21: Infectious disease diagnostic testing market in Americas 2014-2019 ($ billions)
Exhibit 22: Infectious disease diagnostic testing market in EMEA 2014-2019 ($ billions)
Exhibit 23: Infectious disease diagnostic testing market in APAC 2014-2019 ($ billions)
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Key takeaways: Abbott Diagnostics
Exhibit 27: Key takeaways: Alere
Exhibit 28: Key takeaways: bioMerieux
Exhibit 29: Key takeaways: DiaSorin
Exhibit 30: Key takeaways: Roche Diagnostics
Exhibit 31: Abbott Diagnostics: Key business offerings
Exhibit 32: Alere: Business segmentation by revenue 2014
Exhibit 33: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 34: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 35: bioMérieux: Applications by technology
Exhibit 36: DiaSorin: Business segmentation by revenue 2014
Exhibit 37: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 38: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 39: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 40: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 41: Roche Diagnostics: Geographical segmentation by revenue 2014
